BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture

Regulatory Approval Process: BioVaxys Technology Corp. and SpayVac for Wildlife, Inc. have initiated the submission process for regulatory approval of SpayVac's fertility-control vaccines targeting feral horses and free-ranging deer populations, with potential support from the U.S. Bureau of Land Management.

Market Expansion and Efficacy: The expansion of SpayVac's applications now includes commercial aquaculture, offering a single-dose immunocontraceptive solution that could significantly reduce feral horse populations and improve management practices while tapping into a lucrative global market for farm-raised fish.